6-month consequences of COVID-19 in patients discharged from hospital: a cohort study

@article{Huang20216monthCO,
  title={6-month consequences of COVID-19 in patients discharged from hospital: a cohort study},
  author={Chaolin Huang and Lixue Huang and Ye-ming Wang and Xia Li and Lili Ren and Xiaoying Gu and Liang Kang and Li Guo and Min Liu and Xing Zhou and Jianfeng Luo and Zhenghui Huang and Shengjin Tu and Yue Zhao and Li Chen and Decui Xu and Yanping Li and Caihong Li and Lu Peng and Yong Li and Wuxiang Xie and D Cui and Lianhan Shang and Guohui Fan and Jiuyang Xu and Geng Wang and Ying Wang and Jingchuan Zhong and Chen Wang and Jianwei Wang and Dingyu Zhang and Bin Cao},
  journal={Lancet (London, England)},
  year={2021},
  volume={397},
  pages={220 - 232}
}
Background The long-term health consequences of COVID-19 remain largely unclear. The aim of this study was to describe the long-term health consequences of patients with COVID-19 who have been discharged from hospital and investigate the associated risk factors, in particular disease severity. Methods We did an ambidirectional cohort study of patients with confirmed COVID-19 who had been discharged from Jin Yin-tan Hospital (Wuhan, China) between Jan 7, 2020, and May 29, 2020. Patients… Expand

Figures and Tables from this paper

1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study
  • Lixue Huang, Qun Yao, +22 authors Bin Cao
  • Medicine
  • The Lancet
  • 2021
TLDR
Most COVID-19 survivors had a good physical and functional recovery during 1-year follow-up, and had returned to their original work and life after 1 year, and the health status in the cohort at 12 months was still lower than that in the control population. Expand
Long Term Health Consequences of COVID-19 in Hospitalized Patients from North India: A follow up study of upto 12 months
TLDR
Fatigue, myalgia, neuro psychiatric symptoms like depression, anxiety, brain fog and sleep disorder, and breathlessness were found to be significantly more often reported in the elderly population and in those patients who had a severe COVID 19 illness at the time of admission. Expand
Long-Term Outcomes of Patients with Coronavirus Disease 2019 at One Year after Hospital Discharge
TLDR
A significant proportion of COVID-19 patients experienced ongoing symptoms at 1 year from onset of the disease, and one-year mortality among survivors of acute CO VID-19 was 7.5%. Expand
Four-Month Clinical Status of a Cohort of Patients After Hospitalization for COVID-19.
TLDR
Four months after hospitalization for COVID-19, a cohort of patients frequently reported symptoms not previously present, and lung-scan abnormalities were common among those who were tested. Expand
Follow-up study on COVID-19 survivors one year after discharge from hospital
  • Yu-miao Zhao, Chunxia Yang, +16 authors Aiguo Xu
  • Medicine
  • International Journal of Infectious Diseases
  • 2021
TLDR
One year after hospitalization for COVID-19, a cohort of survivors were mainly troubled with muscle fatigue and insomnia, and it is necessary to intervene main target population for long-term recovery. Expand
A prospective study of long-term outcomes among hospitalized COVID-19 patients with and without neurological complications
TLDR
Abnormalities in functional outcomes, ADLs, anxiety, depression and sleep occurred in over 90% of patients 6-months after hospitalization for COVID-19, and patients with neurological complications during index hospitalization had significantly worse 6-month functional outcomes than those without. Expand
A Prospective Study of Long-Term Outcomes Among Hospitalized COVID-19 Patients with and without Neurological Complications
TLDR
Abnormalities in functional outcomes, ADLs, anxiety, depression and sleep occurred in over 90% of patients 6-months after hospitalization for COVID-19, with significantly worse 6-month functional outcomes than those without. Expand
Six-month outcomes and effect of pulmonary rehabilitation among patients hospitalized with COVID-19: a retrospective cohort study
  • Yaoshan Dun, Chao Liu, +8 authors Suixin Liu
  • Medicine
  • Annals of medicine
  • 2021
TLDR
Findings suggest PR may be a strategy to promote the improvement of exercise capacity after COVID-19, and no differences in immunity variables and blood chemistry were observed between groups. Expand
Clinical outcomes and quality of life of COVID-19 survivors: A follow-up of 3 months post hospital discharge
TLDR
Patients hospitalized for COVID-19 frequently face persistent clinical and mental health problems up to 3 months following hospital discharge, with significant impact on patients’ HRQoL, but especially pain/discomfort and anxiety/depression. Expand
Sixty-day consequences of COVID-19 in patients discharged from hospital: an electronic health records study
TLDR
An electronic health records study of community-acquired COVID-19 patients discharged between 15 March and 14 July 2020 from hospitals in Oxfordshire, UK suggests important sex differences in 60-day outcomes following CO VID-19 hospitalization that have not previously been well described. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 41 REFERENCES
Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study
TLDR
It was found that physical decline/fatigue, post-activity polypnea and alopecia were more common in females than in males, and some of these sequelae might be related to gender, age and clinical characteristics during hospitalization. Expand
Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery
TLDR
Radiological and physiological abnormalities were still found in a considerable proportion of COVID-19 survivors without critical cases 3 months after discharge, and higher level of D-dimer levels on admission could effectively predict impaired DLCO after 3 months discharge. Expand
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis.
TLDR
A prospective meta-analysis that pooled data from 7 randomized clinical trials that evaluated the efficacy of corticosteroids in 1703 critically ill patients with COVID-19 found that low-dose dexamethasone reduced mortality in hospitalized patients with Cohen's disease who required respiratory support. Expand
Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
TLDR
In patients hospitalized with Covid-19, the use of dexamethasone resulted in lower 28-day mortality among those who were receiving either invasive mechanical ventilation or oxygen alone at randomization but not among those receiving no respiratory support. Expand
One-year outcomes and health care utilization in survivors of severe acute respiratory syndrome.
TLDR
Most SARS survivors had good physical recovery from their illness, but some patients and their caregivers reported a significant reduction in mental health 1 year later, which should be considered as part of future pandemic planning. Expand
Chest CT and Clinical Follow-up of Discharged Patients with COVID-19 in Wenzhou City, Zhejiang, China
TLDR
The lung damage due to CO VID-19 could be reversible for the common COVID-19 patients A few cases showed recurring positive results of nucleic acid tests after discharge. Expand
Chest Computed Tomography and Clinical Follow-Up of Discharged Patients with COVID-19 in Wenzhou City, Zhejiang, China
TLDR
The lung damage due to CO VID-19 could be reversible for patients with common COVID-19, and a few cases showed recurring positive results of nucleic-acid tests after discharge. Expand
Follow-up Study on Pulmonary Function and Lung Radiographic Changes in Rehabilitating Severe Acute Respiratory Syndrome Patients After Discharge
TLDR
The findings suggest that lung fibrotic changes caused by SARS disease occurred mostly in severely sick patients and may be self-rehabilitated. Expand
CT quantification of pneumonia lesions in early days predicts progression to severe illness in a cohort of COVID-19 patients
TLDR
CT quantification of pneumonia lesions can early and non-invasively predict the progression to severe illness, providing a promising prognostic indicator for clinical management of COVID-19. Expand
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
TLDR
In hospitalized adult patients with severe Covid-19, no benefit was observed with lopinavir–ritonavir treatment beyond standard care, and future trials in patients withsevere illness may help to confirm or exclude the possibility of a treatment benefit. Expand
...
1
2
3
4
5
...